Infections in children with acute myeloid leukemia: increased mortality in relapsed/refractory patients
- 28 May 2019
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 60 (12) , 3028-3035
Abstract
The aim of this nationwide study was to describe the epidemiology and profile of bacterial infections (BI), invasive fungal disease (IFD) and viral infections (VI) in patients with de novo and relapsed/refractory (rel/ref) acute myeloid leukemia (AML). Within the studied group of 250 children with primary AML, at least one infectious complication (IC) was diagnosed in 76.0% (n = 190) children including 85.1% (n = 504) episodes of BI, 8.3% (n = 49) – IFD and 6.6% (n = 39) – VI. Among 61 patients with rel/ref AML, at least one IC was found in 67.2% (n = 41) of children including 78.8% (n = 78) of BI, 14.1% (n = 14) of IFD and 7.1% (n = 7) of VI. In all AML patients, within BI Gram-negative strains were predominant. Half of these strains were multi-drug resistant. Characteristics of IFD and VI were comparable for de novo and rel/ref AML. The infection-related mortality was significantly higher, while survival from infection was significantly lower in patients with rel/ref disease.Keywords
This publication has 25 references indexed in Scilit:
- Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB studyHaematologica, 2018
- Adenovirus Infection in Children With Acute Myeloid LeukemiaThe Pediatric Infectious Disease Journal, 2018
- Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infectionsJournal of Microbiology, Immunology and Infection, 2017
- Invasive fungal infection following chemotherapy for acute myeloid leukaemia—Experience from a developing countryMycoses, 2017
- Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin ProphylaxisJournal of Pediatric Hematology/Oncology, 2017
- Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML‐BFM 2004Pediatric Blood & Cancer, 2016
- Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trialAnnals of Hematology, 2015
- Microbiologically Documented Fungal Infections in Pediatric Patients With Acute Myeloid LeukemiaJournal of Pediatric Hematology/Oncology, 2014
- Second Bacteremia During Antibiotic Treatment in Children With Acute Myeloid Leukemia: A Report From the Canadian Infections in Acute Myeloid Leukemia Research GroupJournal of the Pediatric Infectious Diseases Society, 2014
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study GroupJournal of Clinical Oncology, 2013